Eye DropsALPHRIN · DORTMOX · Advanced Molecules
A focused ophthalmic eye drops portfolio: two flagship products for clinic and perioperative use, plus advanced molecule manufacturing capabilities for qualified distribution partners.
Two drops, built for the workflow.
Eye drops designed to sit naturally beside the intraocular product range, with clean labelling, consistent presentation, and clinical clarity.
From bottle to tissue.
Every drop follows the same path: precise dispensing, corneal contact, absorption, and therapeutic action.
Precision Delivery
Topical ophthalmic drops deliver active molecules through the cornea to the anterior segment. Concentration, contact time, and formulation stability determine therapeutic efficacy.
Next-generation molecules.
Built to order.
Beyond ALPHRIN and DORTMOX, Agaaz has established manufacturing capabilities for a range of advanced ophthalmic molecules and fixed-dose combinations. These formulations are available to qualified distribution partners with committed volume plans, giving access to new-generation eye care products through a single trusted manufacturing source.
See the drops up close.
Clean labelling and packaging, designed to communicate clearly at first glance.
What the published literature says about topical iop-lowering fixed combinations
The clinical case for this product category does not rest on our own material. The studies below are independent, peer-reviewed and indexed in PubMed, and they cover topical iop-lowering fixed combinations as a subject. Each entry links to its PubMed record so the primary source can be read in full.
- Meta-AnalysisEfficacy and tolerability of fixed combination of brimonidine 0.2%/timolol 0.5% compared with fixed combination of dorzolamide 2%/timolol 0.5% in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized controlled trialsBudengeri P et al. (2013) · Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · PMID 23379771
- Meta-AnalysisEfficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trialsHe M et al. (2013) · PloS one · PMID 24349536
- Meta-AnalysisIntraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysisCheng JW et al. (2012) · PloS one · PMID 23028770
Independent peer-reviewed publications indexed in PubMed. Listed as clinical background on the molecule and device class; they are not studies of Agaaz products and imply no endorsement.
Further reading
Common questions about
Agaaz eye drops.
For distributors, procurement teams, and clinic operators.
Want to build your eye drops portfolio?
Share your target market, molecules of interest, and expected volume. We'll respond with availability, pricing, and a documentation checklist.
